This is a routine, small insider sale by a director for tax-related equity compensation purposes. No material read-through for the stock. Monitor for any larger insider sales or changes in ownership patterns, but this filing alone does not warrant a trading response.
Price Chart
Executive Summary
Director Douglas Kerr filed a Form 144 notice of intent to sell 2,443 shares of Dyne Therapeutics common stock, with an estimated aggregate market value of approximately $64,203 based on the filing date. The shares were acquired through vesting of restricted stock units granted under the issuer's equity compensation plan. This is a routine, small-dollar sale relative to the company's $4.9B market cap and does not signal a change in business outlook or management confidence.
Key Facts
- Director Douglas Kerr filed Form 144 to sell 2,443 shares of Dyne Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is approximately $64,203.
- Shares were acquired through vesting of restricted stock units (RSUs) granted under equity compensation plans on 08/12/2026 and 06/05/2026.
- The sale is to be executed through Stifel Nicolaus & Company Inc.
- The filing date is August 13, 2026; the proposed sale is for the open market on Nasdaq.
Financial Impact
Proposed sale of 2,443 shares valued at approximately $64,203 — less than 0.001% of the company's $4.9B market cap.
Risk Factors
- Insider selling could increase if additional directors or officers file Form 144s in coming weeks.
- The sale is not yet executed; the insider may choose not to sell.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001972481-26-000258 |
| Document: 0001972481-26-000258-index.html | 0001972481-26-000258 |
| Document: 0001972481-26-000258.txt | 0001972481-26-000258 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.39 (+41.15%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.39 (−41.15%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.39 (+40.12%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.39 (−40.12%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.39 (−40.12%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.39 (−40.19%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.39 (+33.69%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.39 (−34.37%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.39 (−29.37%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.39 (+30.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access